Why the study?
Does targeting iNOS with antisense oligodeoxynucleotides attenuate acute renal failure in rats subjected to renal ischemia?
Population
Rats subjected to renal ischemia
Design
Preclinical
Authors
Loading...
Hypothesis-generating for iNOS antisense in rodent ischemic AKI; leaves open translation to human trials.
Does targeting iNOS with antisense oligodeoxynucleotides attenuate acute renal failure in rats subjected to renal ischemia?
Selective knock-down of iNOS using antisense oligodeoxynucleotides protects against ischemic acute renal failure in rats, highlighting the cytotoxic role of iNOS-derived NO.
Noiri et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: